All Stories

  1. New Biomarkers in the Diagnosis and Prognosis of Dilated Cardiomyopathy: Pro-Resolving Lipids and miRNAs
  2. Atrial Myopathy and Heart Failure: Immunomolecular Mechanisms and Clinical Implications
  3. Correction: Povo-Retana et al. Trabectedin and Lurbinectedin Modulate the Interplay between Cells in the Tumour Microenvironment—Progresses in Their Use in Combined Cancer Therapy. Molecules 2024, 29, 331
  4. Lipoxin A4 levels correlate with severity in a Spanish COVID-19 cohort: potential use of endogenous pro-resolving mediators as biomarkers
  5. Percutaneous pulmonary thrombectomy with aspiration catheters in patients with high-risk pulmonary embolism and absolute contraindication to systemic thrombolysis
  6. Interleuquina-6 como marcador pronóstico en el fracaso renal agudo y su regulación dependiente de klotho
  7. Potential Beneficial Role of Nitric Oxide in SARS-CoV-2 Infection: Beyond Spike-Binding Inhibition
  8. Fructose-2,6-bisphosphate restores DNA repair activity of PNKP and ameliorates neurodegenerative symptoms in Huntington’s disease
  9. Endogenous LXR signaling controls pulmonary surfactant homeostasis and prevents lung inflammation
  10. Beneficial effects of hepatic cyclooxygenase‐2 expression against cholestatic injury after common bile duct ligation in mice
  11. Role of NOD1 in atrial myopathy associated with heart failure
  12. Sex differences in cardiac ferroptosis after acute myocardial infarction in wild type and aryl hydrocarbon receptor knockout mice
  13. Reprogramming of the LXRα Transcriptome Sustains Macrophage Secondary Inflammatory Responses
  14. Biomarkers in Contrast-Induced Acute Kidney Injury: Towards A New Perspective
  15. Biomarkers in Contrast-Induced Acute Kidney Injury: Towards a new perspective.
  16. Contribution of Nucleotide-Binding Oligomerization Domain-like (NOD) Receptors to the Immune and Metabolic Health
  17. Trabectedin and Lurbinectedin Modulate the Interplay between Cells in the Tumour Microenvironment—Progresses in Their Use in Combined Cancer Therapy
  18. Transcriptomic and lipid profiling analysis reveals a functional interplay between testosterone and growth hormone in hypothyroid liver
  19. 3,4-dimethoxychalcone induces autophagy and reduces neointimal hyperplasia and aortic lesions in mouse models of atherosclerosis
  20. Lipoxin-mediated signaling: ALX/FPR2 interaction and beyond
  21. Fructose-2,6-bisphosphate restores DNA repair activity of PNKP and ameliorates neurodegenerative symptoms in Huntington’s disease
  22. Immunometabolic actions of trabectedin and lurbinectedin on human macrophages: relevance for their anti-tumor activity
  23. Saturated fatty acid-enriched small extracellular vesicles mediate a crosstalk inducing liver inflammation and hepatocyte insulin resistance
  24. Defining the metabolic signatures associated with human macrophage polarisation
  25. Editorial: Women in gastrointestinal cancers, volume II: 2022
  26. Trabectedin modulates macrophage polarization in the tumor-microenvironment. Role of KV1.3 and KV1.5 channels
  27. Crosstalk between P2Y receptors and cyclooxygenase activity in inflammation and tissue repair
  28. Inhibition of LXR controls the polarization of human inflammatory macrophages through upregulation of MAFB
  29. Immunometabolic actions of trabectedin and lurbinectedin on human macrophages: Relevance for their antitumor activity
  30. Beneficial effect of TLR4 blockade by a specific aptamer antagonist after acute myocardial infarction
  31. Free triiodothyronine levels and age influences the metabolic profile and COVID-19 severity parameters in euthyroid and levothyroxine-treated patients
  32. Quantitative Proteomics Analysis Reveals That Cyclooxygenase-2 Modulates Mitochondrial Respiratory Chain Complex IV in Cardiomyocytes
  33. Unraveling the interplay between iron homeostasis, ferroptosis and extramedullary hematopoiesis
  34. COX-2 Expression in Hepatocytes Improves Mitochondrial Function after Hepatic Ischemia-Reperfusion Injury
  35. Functional Crosstalk between PCSK9 Internalization and Pro-Inflammatory Activation in Human Macrophages: Role of Reactive Oxygen Species Release
  36. High-fat diet activates splenic NOD1 and enhances neutrophil recruitment and neutrophil extracellular traps release in the spleen of ApoE-deficient mice
  37. Specialized Proresolving Mediators Protect Against Experimental Autoimmune Myocarditis by Modulating Ca2+ Handling and NRF2 Activation
  38. Use of 11C-acetate PET imaging in the evaluation of advanced atherogenic lesions
  39. The Aryl Hydrocarbon Receptor Ligand FICZ Improves Left Ventricular Remodeling and Cardiac Function at the Onset of Pressure Overload-Induced Heart Failure in Mice
  40. NOD1 splenic activation confers ferroptosis protection and reduces macrophage recruitment under pro-atherogenic conditions
  41. High Fat Diet Activates Splenic NOD1 and Enhances Neutrophil Recruitment and Neutrophil Extracellular Traps Release in the Spleen of ApoE-Deficient Mice
  42. Immuno-Modulation to Treat Common Cardiovascular Diseases
  43. Graphene Particles Interfere with Pro‐Inflammatory Polarization of Human Macrophages: Functional and Electrophysiological Evidence
  44. NOD1 in the interplay between microbiota and gastrointestinal immune adaptations
  45. Beyond classic concepts in thyroid homeostasis: Immune system and microbiota
  46. Crosstalk Between LXR and Caveolin-1 Signaling Supports Cholesterol Efflux and Anti-Inflammatory Pathways in Macrophages
  47. NOD1-Targeted Immunonutrition Approaches: On the Way from Disease to Health
  48. Resolution-Based Therapies: The Potential of Lipoxins to Treat Human Diseases
  49. Chronic treatment with acetaminophen protects against liver aging by targeting inflammation and oxidative stress
  50. Contribution of Extramedullary Hematopoiesis to Atherosclerosis. The Spleen as a Neglected Hub of Inflammatory Cells
  51. Specific Effects of Trabectedin and Lurbinectedin on Human Macrophage Function and Fate—Novel Insights
  52. Deletion or Inhibition of NOD1 Favors Plaque Stability and Attenuates Atherothrombosis in Advanced Atherogenesis
  53. NOD1 deficiency promotes an imbalance of thyroid hormones and microbiota homeostasis in mice fed high fat diet
  54. Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
  55. Innate Immune Receptors, Key Actors in Cardiovascular Diseases
  56. BML‐111 treatment prevents cardiac apoptosis and oxidative stress in a mouse model of autoimmune myocarditis
  57. GRK2 levels in myeloid cells modulate adipose-liver crosstalk in high fat diet-induced obesity
  58. Tumor stem cells fuse with monocytes to form highly invasive tumor-hybrid cells
  59. CIBER-CLAP (CIBERCV Cardioprotection Large Animal Platform): A multicenter preclinical network for testing reproducibility in cardiovascular interventions
  60. Transition of Macrophages to Fibroblast-Like Cells in Healing Myocardial Infarction
  61. Self-defense of macrophages against oxidative injury: Fighting for their own survival
  62. Amyloid Peptide Induced Neuroinflammation Increases the P2X7 Receptor Expression in Microglial Cells, Impacting on Its Functionality
  63. LXR Signaling Regulates Macrophage Survival and Inflammation in Response to Ionizing Radiation
  64. Protective Role of Hepatocyte Cyclooxygenase-2 Expression Against Liver Ischemia-Reperfusion Injury in Mice
  65. Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort
  66. Common and Differential Transcriptional Actions of Nuclear Receptors Liver X Receptors α and β in Macrophages
  67. Post-translational modifications of prostaglandin-endoperoxide synthase 2 in colorectal cancer: An update
  68. Endothelial NOD1 directs myeloid cell recruitment in atherosclerosis through VCAM‐1
  69. Benzylamine and Thenylamine Derived Drugs Induce Apoptosis and Reduce Proliferation, Migration and Metastasis Formation in Melanoma Cells
  70. The P34G mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras.
  71. Protection against gamma-radiation injury by protein tyrosine phosphatase 1B
  72. Deficiency of NOD1 Improves the β-Adrenergic Modulation of Ca2+ Handling in a Mouse Model of Heart Failure
  73. Correction: Induction of nitric oxide synthase-2 proceeds with the concomitant downregulation of the endogenous caveolin levels (doi:10.1242/jcs.01002)
  74. PGE2 induces apoptosis of hepatic stellate cells and attenuates liver fibrosis in mice by downregulating miR-23a-5p and miR-28a-5p
  75. GQ-11: A new PPAR agonist improves obesity-induced metabolic alterations in LDLr−/− mice
  76. Prostaglandin E2 Impairs P2Y2/P2Y4 Receptor Signaling in Cerebellar Astrocytes via EP3 Receptors
  77. Expression of Concern: Induction of nitric oxide synthase-2 proceeds with the concomitant downregulation of the endogenous caveolin levels. J. Cell Sci. doi: 10.1242/jcs.01002
  78. Mild and Short-Term Caloric Restriction Prevents Obesity-Induced Cardiomyopathy in Young Zucker Rats without Changing in Metabolites and Fatty Acids Cardiac Profile
  79. Cyclooxygenase 2 in liver dysfunction and carcinogenesis: Facts and perspectives
  80. Role of NOD1 in Heart Failure Progression via Regulation of Ca 2+ Handling
  81. Cell Expansion-Dependent Inflammatory and Metabolic Profile of Human Bone Marrow Mesenchymal Stem Cells
  82. NOD1 activation in cardiac fibroblasts induces myocardial fibrosis in a murine model of type 2 diabetes
  83. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice
  84. New thiazolidinediones affect endothelial cell activation and angiogenesis
  85. GM-CSF Enhances Macrophage Glycolytic Activity In Vitro and Improves Detection of Inflammation In Vivo
  86. New PPARγ partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr−/− mice
  87. Activation of autophagy in macrophages by pro-resolving lipid mediators
  88. New indole-thiazolidine attenuates atherosclerosis in LDLr−/− mice
  89. Metabolic signatures linked to macrophage polarization: from glucose metabolism to oxidative phosphorylation
  90. Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer
  91. HIF-1α and PFKFB3 Mediate a Tight Relationship Between Proinflammatory Activation and Anerobic Metabolism in Atherosclerotic Macrophages
  92. Regulation of MicroRNA 183 by Cyclooxygenase 2 in Liver Is DEAD-Box Helicase p68 (DDX5) Dependent: Role in Insulin Signaling
  93. NOD1, a new player in cardiac function and calcium handling
  94. A labdane diterpene exerts ex vivo and in vivo cardioprotection against post-ischemic injury: Involvement of AKT-dependent mechanisms
  95. NOD1 receptor is up-regulated in diabetic human and murine myocardium
  96. Hepatic Cyclooxygenase-2 Expression Protects Against Diet-Induced Steatosis, Obesity, and Insulin Resistance
  97. NFκB2/p100 Is a Key Factor for Endotoxin Tolerance in Human Monocytes: A Demonstration Using Primary Human Monocytes from Patients with Sepsis
  98. Anti-inflammatory Actions of Acanthoic Acid-Related Diterpenes Involve Activation of the PI3K p110γ/δ Subunits and Inhibition of NF-κB
  99. P727Nucleotide-binding oligomerization domain-containing protein 1-signaling is upregulated in hearts from type 2 diabetic mice
  100. Mitochondrial DAMPs Induce Endotoxin Tolerance in Human Monocytes: An Observation in Patients with Myocardial Infarction
  101. Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD
  102. Pivotal role of protein tyrosine phosphatase 1B (PTP1B) in the macrophage response to pro-inflammatory and anti-inflammatory challenge
  103. Involvement of monocytes/macrophages as key factors in the development and progression of cardiovascular diseases
  104. 2-deoxy-2-[18F]fluoro-d-mannose positron emission tomography imaging in atherosclerosis
  105. Sustained Release of Prostaglandin E2in Fibroblasts Expressing Ectopically Cyclooxygenase 2 Impairs P2Y-Dependent Ca2+-Mobilization
  106. Modulation of Voltage-Dependent and Inward Rectifier Potassium Channels by 15-Epi-Lipoxin-A4 in Activated Murine Macrophages: Implications in Innate Immunity
  107. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma
  108. Progression of liver oncogenesis in the double transgenic mice c-myc/TGF α is not enhanced by cyclooxygenase-2 expression
  109. Prolonged leptin treatment increases transient outward K+ current via upregulation of Kv4.2 and Kv4.3 channel subunits in adult rat ventricular myocytes
  110. Selective Impairment of P2Y Signaling by Prostaglandin E2 in Macrophages: Implications for Ca2+-Dependent Responses
  111. Identification of a novel Pfkfb1 mRNA variant in rat fetal liver
  112. Cyclooxygenase-2 Is a Target of MicroRNA-16 in Human Hepatoma Cells
  113. NOD1 Activation Induces Cardiac Dysfunction and Modulates Cardiac Fibrosis and Cardiomyocyte Apoptosis
  114. Cardiotrophin-1 induces sarcoplasmic reticulum Ca2+ leak and arrhythmogenesis in adult rat ventricular myocytes
  115. Evaluation of epigenetic modulation of cyclooxygenase-2 as a prognostic marker for hepatocellular carcinoma
  116. Propiedades antiinflamatorias de los ácidos grasos poliinsaturados omega-3. Indicaciones en oftalmología
  117. Critical role of the death receptor pathway in the antitumoral effects induced by hispanolone derivatives
  118. Protein Kinase C (PKC)ζ-mediated GαqStimulation of ERK5 Protein Pathway in Cardiomyocytes and Cardiac Fibroblasts
  119. Relevance of the MEK/ERK Signaling Pathway in the Metabolism of Activated Macrophages: A Metabolomic Approach
  120. Labdane diterpenes protect against anoxia/reperfusion injury in cardiomyocytes: involvement of AKT activation
  121. Anti-Inflammatory and Antioxidant Properties of a New Arylidene-Thiazolidinedione in Macrophages
  122. Cot/tpl2 activity is required for TLR-induced activation of the Akt p70 S6k pathway in macrophages: Implications for NO synthase 2 expression
  123. Transgenic Mice Expressing Cyclooxygenase-2 in Hepatocytes Reveal a Minor Contribution of This Enzyme to Chemical Hepatocarcinogenesis
  124. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C
  125. Benznidazole blocks NF-κB activation but not AP-1 through inhibition of IKK
  126. Retinoid X receptor α controls innate inflammatory responses through the up-regulation of chemokine expression
  127. Substrate Fate in Activated Macrophages: A Comparison between Innate, Classic, and Alternative Activation
  128. Cilastatin Attenuates Cisplatin-Induced Proximal Tubular Cell Damage
  129. Electronegative LDL induction of apoptosis in macrophages: Involvement of Nrf2
  130. ILK mediates LPS-induced vascular adhesion receptor expression and subsequent leucocyte trans-endothelial migration†
  131. Bioactivity of nitrolinoleate: effects on adhesion molecules and CD40–CD40L system☆
  132. Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K/Akt and the ERK/Nrf-2 defense pathways
  133. Mice Lacking Thyroid Hormone Receptor β Show Enhanced Apoptosis and Delayed Liver Commitment for Proliferation after Partial Hepatectomy
  134. COX-2 in liver, from regeneration to hepatocarcinogenesis: What we have learned from animal models?
  135. Impairment of Transforming Growth Factor β Signaling in Caveolin-1-deficient Hepatocytes
  136. Vasorelaxant and anti-platelet aggregation effects of aqueous Ocimum basilicum extract
  137. Constitutive COX-2 activity in cardiomyocytes confers permanent cardioprotection
  138. Constitutive expression of cyclo-oxygenase 2 transgene in hepatocytes protects against liver injury
  139. Implication of Glutamate in the Expression of Inducible Nitric Oxide Synthase After Oxygen and Glucose Deprivation in Rat Forebrain Slices
  140. Supression of inflammatory responses by labdane-type diterpenoids☆
  141. Kaurane diterpenes protect against apoptosis and inhibition of phagocytosis in activated macrophages
  142. Selective Impairment of Nuclear Factor-κB-Dependent Gene Transcription in Adult Cardiomyocytes
  143. Atherogenesis takes place in cholesterol-fed rabbits when circulating concentrations of endogenous cortisol are increased and inflammation suppressed
  144. TLR4-Mediated Survival of Macrophages Is MyD88 Dependent and Requires TNF-α Autocrine Signalling
  145. Selective Activation of Liver X Receptors by Acanthoic Acid-Related Diterpenes
  146. Animal models for the study of liver regeneration: role of nitric oxide and prostaglandins
  147. Dispensability and dynamics of caveolin-1 during liver regeneration and in isolated hepatic cells
  148. Identification of conserved domains in the promoter regions of nitric oxide synthase 2: implications for the species-specific transcription and evolutionary differences
  149. Protection against Fas-induced liver apoptosis in transgenic mice expressing cyclooxygenase 2 in hepatocytes
  150. Infiltration of Inflammatory Cells Plays an Important Role in Matrix Metalloproteinase Expression and Activation in the Heart during Sepsis
  151. Surgical Excision of Bone Sarcomas Involving the Sacroiliac Joint
  152. Cyclo-oxygenase 2 expression impairs serum-withdrawal-induced apoptosis in liver cells
  153. Specific Contribution of p19ARF to Nitric Oxide-Dependent Apoptosis
  154. The flavonoid quercetin induces apoptosis and inhibits JNK activation in intimal vascular smooth muscle cells
  155. Involvement of mitogen-activated protein kinases in the symbiosis Bradyrhizobium-Lupinus
  156. Cyclooxygenase 2: understanding the pathophysiological role through genetically altered mouse models
  157. The Nonthiazolidinedione PPARγ Agonist L-796,449 Is Neuroprotective in Experimental Stroke
  158. Potentiation of tumor formation by topical administration of 15-deoxy-Δ 12,14 -prostaglandin J 2 in a model of skin carcinogenesis
  159. Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2 Cause Potent Neuroprotection after Experimental Stroke through Noncompletely Overlapping Mechanisms
  160. Assessment of a dual regulatory role for NO in liver regeneration after partial hepatectomy: protection against apoptosis and retardation of hepatocyte proliferation
  161. Prostaglandin E 2 promotes migration and adhesion in hepatocellular carcinoma cells
  162. Nitric oxide and cell viability in inflammatory cells: a role for NO in macrophage function and fate
  163. Nitric Oxide and Cell Signaling: In Vivo Evaluation of NO‐Dependent Apoptosis by MRI and Not NMR Techniques
  164. PGE1-induced NO reduces apoptosis by D-galactosamine through attenuation of NF-κB and NOS-2 expression in rat hepatocytes
  165. A New Family of Synthetic Diterpenes that Regulates Cytokine Synthesis by Inhibiting IκBα Phosphorylation
  166. Attenuation of NF-?B signalling in rat cardiomyocytes at birth restricts the induction of inflammatory genes
  167. Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins
  168. The P34G Mutation Reduces the Transforming Activity of K-Ras and N-Ras in NIH 3T3 Cells but Not of H-Ras
  169. Simultaneous abrogation of NOS-2 and COX-2 activities is lethal in partially hepatectomised mice
  170. Thioacetamide-induced liver regeneration involves the expression of cyclooxygenase 2 and nitric oxide synthase 2 in hepatocytes
  171. Induction of nitric oxide synthase-2 proceeds with the concomitant downregulation of the endogenous caveolin levels
  172. Regional distribution of hyperpolarization-activated current (If) and hyperpolarization-activated cyclic nucleotide-gated channel mRNA expression in ventricular cells from control and hypertrophied rat hearts
  173. Sustained Nitric Oxide Delivery Delays Nitric Oxide-Dependent Apoptosis in Macrophages: Contribution to the Physiological Function of Activated Macrophages
  174. Thromboxane A 2 -Induced Inhibition of Voltage-Gated K + Channels and Pulmonary Vasoconstriction
  175. Induction of Cyclooxygenase-2 Accounts for Restraint Stress-Induced Oxidative Status in Rat Brain
  176. The cyclopentenone 15-deoxy-Δ 12,14 -prostaglandin J 2 binds to and activates H-Ras
  177. The nNOS inhibitor, AR-R17477AR, prevents the loss of NF68 immunoreactivity induced by methamphetamine in the mouse striatum
  178. Ammonia prevents glutamate-induced but not low K+-induced apoptosis in cerebellar neurons in culture
  179. PKCε is a permissive link in integrin-dependent IFN-γ signalling that facilitates JAK phosphorylation of STAT1
  180. Selective Inhibitors of Cyclooxygenase-2 Delay the Activation of Nuclear Factor κB and Attenuate the Expression of Inflammatory Genes in Murine Macrophages Treated with Lipopolysaccharide
  181. Potentiation of Protein Kinase C ζ Activity by 15-Deoxy-Δ12,14-Prostaglandin J2 Induces an Imbalance between Mitogen-Activated Protein Kinases and NF-κB That Promotes Apoptosis in Macrophages
  182. Presence of methylated arginine derivatives in orthotopic human liver transplantation: Relevance for liver function
  183. H-Ras-specific activation of NF-κB protects NIH 3T3 cells against stimulus-dependent apoptosis
  184. Interleukin-4 and interleukin-10 modulate nuclear factor κB activity and nitric oxide synthase-2 expression in Theiler's virus-infected brain astrocytes
  185. Induction of apoptosis by nitric oxide in macrophages is independent of apoptotic volume decreas
  186. Coexistence of translocated cytochrome c and nitrated protein in neurons of the rat cerebral cortex after oxygen and glucose deprivation
  187. The Increase in TNF-α Levels Is Implicated in NF-κB Activation and Inducible Nitric Oxide Synthase Expression in Brain Cortex after Immobilization Stress
  188. Absence of nuclear factor κB inhibition by NSAIDs in hepatocytes
  189. Nitric oxide and resolution of inflammation
  190. Chronic Stress Induces the Expression of Inducible Nitric Oxide Synthase in Rat Brain Cortex
  191. Protein Kinase Cϵ Is Required for Macrophage Activation and Defense Against Bacterial Infection
  192. Intracellular water motion decreases in apoptotic macrophages after caspase activation
  193. Contribution of cyclooxygenase-2 to liver regeneration after partial hepatectomy
  194. Peroxisome Proliferator-activated Receptor-γ-independent Inhibition of Macrophage Activation by the Non-thiazolidinedione Agonist L-796,449
  195. Up-regulation of TNF-α convertase (TACE/ADAM17) after oxygen–glucose deprivation in rat forebrain slices
  196. Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and -9 in fetal rat hepatocytes
  197. Inhibition of the Nuclear Factor  B (NF- B) Pathway by Tetracyclic Kaurene Diterpenes in Macrophages: SPECIFIC EFFECTS ON NF- B-INDUCING KINASE ACTIVITY AND ON THE COORDINATE ACTIVATION OF ERK AND p38 MAPK
  198. Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor κB-mediated mechanisms
  199. Contribution of Cyclopentenone Prostaglandins to the Resolution of Inflammation Through the Potentiation of Apoptosis in Activated Macrophages
  200. Regulation of cyclooxygenase 2 expression in hepatocytes by CCAAT/enhancer-binding proteins
  201. Mechanisms of the neuroprotective effect of aspirin after oxygen and glucose deprivation in rat forebrain slices
  202. Localisations métastatiques atypiques d’un cancer du rectum
  203. Anti-inflammatory action of type I interferons deduced from mice expressing interferon β
  204. Inhibition of IκB Kinase and IκB Phosphorylation by 15-Deoxy-Δ12,14-Prostaglandin J2 in Activated Murine Macrophages
  205. Inhibitory effect of IGF-I on type 2 nitric oxide synthase expression in Ins-1 cells and protection against activation-dependent apoptosis: involvement of phosphatidylinositol 3-kinase
  206. Inhibition of NOS-2 expression in macrophages through the inactivation of NF-κ B by andalusol
  207. Mechanisms of Nitric Oxide-Dependent Apoptosis: Involvement of Mitochondrial Mediators
  208. Presence of a nitric oxide synthase inhibitor in the graft efflux during reperfusion in human liver transplantation
  209. Protective effect of cyclosporin A and FK506 from nitric oxide-dependent apoptosis in activated macrophages
  210. Down-Regulation of Neuronal Nitric Oxide Synthase by Nitric Oxide After Oxygen-Glucose Deprivation in Rat Forebrain Slices
  211. Expression of cyclooxygenase-2 in foetal rat hepatocytes stimulated with lipopolysaccharide and pro-inflammatory cytokines
  212. Interferon-α/β Inhibits the Apoptosis Induced by Lipopolysaccharide and Interferon-γ in Murine Peritoneal Macrophages
  213. Suppression of HIV-1 infection in linomide-treated SCID-hu-PBL mice
  214. Neuronal expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices
  215. Differential regulation of nitric oxide synthase mRNA expression by lipopolysaccharide and pro-inflammatory cytokines in fetal hepatocytes treated with cycloheximide
  216. Nuclear factorκB is required for the transcriptional control of type II NO synthase in regenerating liver
  217. Rapid Up-regulation of IκBβ and Abrogation of NF-κB Activity in Peritoneal Macrophages Stimulated with Lipopolysaccharide
  218. Requirement of nitric oxide and calcium mobilization for the induction of apoptosis in adrenal vascular endothelial cells
  219. Nitric oxide induces apoptosis via triggering mitochondrial permeability transition
  220. Absence of NO synthase type II expression in fetal liver from pregnant rats under septic shock conditions
  221. Involvement of nitric oxide synthesis in hepatic perturbations induced in rats by a necrogenic dose of thioacetamide
  222. Expression of the calcium-independent cytokine-inducible (iNOS) isoform of nitric oxide synthase in rat placenta
  223. Regulation of rat liver S-adenosylmethionine synthetase during septic shock: Role of nitric oxide
  224. Up-Regulation of Protein Kinase C-ϵ Promotes the Expression of Cytokine-inducible Nitric Oxide Synthase in RAW 264.7 Cells
  225. Evidence for Common Mechanisms in the Transcriptional Control of Type II Nitric Oxide Synthase in Isolated Hepatocytes
  226. Differential expression pattern of S-adenosylmethionine synthetase isoenzymes during rat liver development
  227. Bacterial lipopolysaccharide antagonizes transforming growth factor ?1-induced apoptosis in primary cultures of hepatocytes
  228. CD53 Antigen and Epidermal Growth Factor Induce Similar Changes in the Pattern of Phorbol Ester Binding in a B Cell Lymphoma
  229. Multiple forms of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase are expressed in perinatal rat liver
  230. Characterization of nitric oxide dependent changes in carbohydrate hepatic metabolism during septic shock
  231. Differential regulation of the expression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and pyruvate kinase by cyclic adenosine 3′,5′-monophosphate in fetal and adult hepatocytes
  232. Epidermal growth factor inhibits cytokine-dependent nitric oxide synthase expression in hepatocytes
  233. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels.
  234. Bacterial Lipopeptides Induce Nitric Oxide Synthase and Promote Apoptosis through Nitric Oxide-independent Pathways in Rat Macrophages
  235. Nitric oxide is released in regenerating liver after partial hepatectomy*1
  236. Platelet-activating factor: the effector of protein-rich plasma extravasation and nitric oxide synthase induction in rat immune complex peritonitis
  237. Protein kinase C (PKC)-induced PKC degradation: a model for down-regulation
  238. Characterization of Signals Leading to Clonal Expansion or to Cell Death During Lymphocyte B Cell Activation
  239. From Apoptosis to Autoimmunity: Insights from the Signaling Pathways Leading to Proliferation or to Programmed Cell Death
  240. Nitric Oxide Implication in the Control of Neurosecretion by Chromaffin Cells
  241. CD2-CD48 interaction prevents apoptosis in murine B lymphocytes by up-regulating bcl-2 expression
  242. Cocaine-induced liver injury in mice elicits specific changes in DNA ploidy and induces programmed death of hepatocytes
  243. Protein kinase C V3 domain mutants with differential sensitivities to m-calpain are not resistant to phorbol-ester-induced down-regulation
  244. Induction of nitric oxide release by MRC OX-44 (anti-CD53) through a protein kinase C-dependent pathway in rat macrophages
  245. Relationship between genomic DNA ploidy and parameters of liver damage during necrosis and regeneration induced by thioacetamide
  246. Rat liver messenger ribonucleic acid and enzyme activity of 6- phosphofructo 2-kinase/fructose 2,6-bisphosphatase impairment during the late period of pregnancy
  247. Rat liver messenger ribonucleic acid and enzyme activity of 6-phosphofructo 2-kinase/fructose 2,6-bisphosphatase impairment during the late period of pregnancy.
  248. Sulfonylureas activate glycogen phosphorylase and increase cytosolic free-Ca2+ levels in isolated rat hepatocytes
  249. Phorbol esters induce nitric oxide synthase and increase arginine influx in cultured peritoneal macrophages
  250. Signal Transduction Pathways Involved in B-Cell Induction
  251. Circular dichroism analysis of ligand-induced conformational changes in protein kinase C. Mechanism of translocation of the enzyme from the cytosol to the membranes and its implications
  252. Differential calcium mobilization by vasopressin, angiotensin II, gastrin-releasing peptide, and adenosine triphosphate in adult and fetal hepatocytes. Relevance for the activation of calcium-dependent enzymes
  253. Differential calcium mobilization by vasopressin, angiotensin II, gastrin-releasing peptide, and adenosine triphosphate in adult and fetal hepatocytes. Relevance for the activation of calcium-dependent enzymes.
  254. Isoenzymes of carbohydrate metabolism in primary cultures of hepatocytes from thioacetamide-induced rat liver necrosis: Responses to growth factors
  255. Phorbol esters, bombesin and insulin elicit differential responses on the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase system in primary cultures of foetal and adult rat hepatocytes
  256. Inhibition of 6-phosphofructo-2-kinase activity by mercaptopurines
  257. Characterization of 6-phosphofructo-2-kinase from foetal-rat liver
  258. Inactivation of 6-phosphofructo-2-kinase during anaerobiosis in the marine whelk Busycon canaliculatum
  259. Substrate specificity of protein kinase C inhibitors
  260. Lack of translocation of protein kinase C from the cytosol to the membranes in vasopressin-stimulated hepatocytes
  261. Substrate-dependent inhibition of protein kinase C by specific inhibitors
  262. Identification of an anti-A and anti-B blood group glycosyltransferase antibody after incompatible bone marrow transplant
  263. Lack of correlation betwen translocation and biological effects mediated by protein kinase C: an appraisal
  264. Oleate-induced translocation of protein kinase C to hepatic microsomal membranes
  265. Translocation of phosphatidate phosphohydrolase from the cytosol to microsomal membranes in thioacetamide-induced liver tumours in rats
  266. Glucagon-induced changes in fructose 2,6-bisphosphate and 6-phosphofructo-2-kinase in cultured rat foetal hepatocytes
  267. Presence of antibody to A- and B-transferases in minor incompatible bone marrow transplants
  268. Age-related changes in the translocation of phosphatidate phosphohydrolase from the cytosol to microsomal membranes in rat liver
  269. Phorbol 12,13-dibutyrate and mitogens increase fructose 2,6-bisphosphate in lymphocytes. Comparison of lymphocyte and rat-liver 6-phosphofructo-2-kinase
  270. Phorbol ester translocation of protein kinase C in guinea-pig synaptosomes and the potentiation of calcium-dependent glutamate release
  271. Activation of protein kinase C from B lymphocytes by lipid A
  272. Fructose 2,6-bisphosphate in isolated foetal hepatocytes
  273. Expression of the v-src or v-fps oncogene increases fructose 2,6-bisphosphate in chick-embryo fibroblasts. Novel mechanism for the stimulation of glycolysis by retroviruses
  274. Effect of glutamine on fructose 2,6-bisphosphate and on glucose metabolism in HeLa cells and in chick-embryo fibroblasts
  275. Phorbol 12-myristate 13-acetate and insulin increase the concentration of fructose 2,6-bisphosphate and stimulate glycolysis in chicken embryo fibroblasts.
  276. The effect of fructose 2,6-bisphosphate on muscle fructose-1,6-bisphosphatase activity
  277. A problematic enzyme
  278. Difference in glucose sensitivity of liver glycolysis and glycogen synthesis. Relationship between lactate production and fructose 2,6-bisphosphate concentration
  279. Is phosphofructokinase the rate-limiting step of glycolysis?
  280. Biphasic effect of fructose 2,6-bisphosphate on the liver fructose-1,6-bisphosphatase: mechanistic and physiological implications
  281. Specific activation by fructose 2,6-bisphosphate and inhibition by P-enolpyruvate of ascites tumor phosphofructokinase
  282. Mitochondrial Membrane-Bound Hexokinase of Ascites Tumor Cells. Functional Implications of Lysine Residues Studied by Modification with Imidoesters
  283. Measurement of NOS mRNA by Northern Blotting and the Ribonuclease-Protection Assay